Cranberries for prevention of recurrent urinary tract infections: An evidence based review
DOI:
https://doi.org/10.32385/rpmgf.v27i5.10888Keywords:
Cranberry, Urinary Tract Infection, Vaccinium macrocarponAbstract
Introduction: Urinary tract infections (UTIs) are an important health problem, both in terms of morbidity and economic impact. Emerging antibiotic resistance increases the need for alternative preventive approaches. Aim: To review the available evidence on the efficacy of cranberries in preventing recurrent uncomplicated UTIs in adult women. Sources: MEDLINE database and the following evidence based medical sites: UpToDate, Clinical Evidence, Bandolier, EBM Online, ACP Journal Club, TRIP, InfoPOEMs, The Cochrane Library, DARE, Guidelines Finder, National Guideline Clearinghouse, Canadian Medical Association Infobase, USPSTF, NIC and Canadian Task Force on Preventive Health Care. Methods: Search for systematic reviews, meta-analyses, clinical guidelines and randomized clinical trials published between January 2000 and December 2010 in English, Portuguese and Spanish. We used the MeSH terms: Vaccinium macrocarpon and UTI and the word cranberry. The American Family Physician`s Strength of Recommendation Taxonomy was used to establish the quality of the studies and define the strength of the recommendation. Results: Of the 127 articles found, only nine fulfilled the inclusion criteria and were selected. These included one clinical decision support system, three systematic reviews, four clinical guidelines and one clinical trial. In its various forms, cranberries seem to effectively decrease the recurrence of UTIs in adult women without associated comorbidities Discussion: Available evidence shows that cranberries are beneficial in preventing recurrent urinary infections (Strength of Recommendation B). However, this recommendation is limited by the heterogeneity of studies and lack of agreement concerning dosage and presentation. Better studies are needed to establish safety and tolerability as well as the adequate dosage, presentation and duration of the treatment.Downloads
Downloads
Published
Issue
Section
License
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.